卡尔西托宁基因相关 (CGRP) 在体腺瘤中的表达:对临床过程和治疗结果的影响
Neuroendocrinology
|February 26, 2026
概括
素基因相关 (CGRP) 存在于 pituitary 腺瘤中,但不存在于非功能性腺瘤中. 在壮病患者手术后,CGRP存在可能与更多的头痛和较低的缓解率有关.
科学领域:
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
- 在瘤学瘤学.
背景情况:
- 素基因相关 (CGRP) 是一种具有血管扩张,炎症和疼痛相关功能的神经.
- 在某些癌症中,CGRP会影响瘤微环境.
- CGRP在垂体腺瘤发育 (腺生成) 中的作用尚不清楚.
研究的目的:
- 为了研究CGRP表达在壮和非功能性垂体腺瘤 (NFPA) 组织中的表达.
- 探索CGRP表达与瘤特征,临床症状和治疗结果之间的关联.
主要方法:
- 免疫组织化学用于检测49个垂体瘤样本中的CGRP (30个瘤,19个NFPA).
- 瘤样本使用特定的多克隆抗体对CGRP进行分析.
- 收集了临床,放射学和组织病理学数据,包括激素染色和Ki-67的数据.
主要成果:
- 在50%的缩性瘤中发现了CGRP阳性,但没有NFPA瘤 (p<0.001).
- CGRP表达与瘤大小,入侵或对治疗的抗性无关.
- 患有CGRP阳性瘤的宏壮病患者表现出更频繁的头痛和更低的术后缓解率的趋势.
结论:
- CGRP在产生体内激素的腺瘤 (巨瘤) 中显著存在,但在NFPA中不存在.
- 在腺瘤组织中检测到CGRP可能表明持续性头痛的可能性更高,并且在巨中治疗成功率降低.
相关概念视频
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
54
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
54
Synthesis and Functions of Calcitonin
4.9K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
4.9K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K


